What is Ultragenyx Pharmaceutical's capex?

Ultragenyx Pharmaceutical (RARE) reported capex of $1M in Q1 2026.

How has Ultragenyx Pharmaceutical's capex changed year-over-year?

Ultragenyx Pharmaceutical's capex decreased by 0.0% year-over-year, from $1M to $1M.

What is the long-term trend for Ultragenyx Pharmaceutical's capex?

Over 4 years (2021 to 2025), Ultragenyx Pharmaceutical's capex has grown at a -46.5% compound annual growth rate (CAGR), from $73.09M to $6M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Ultragenyx Pharmaceutical RARE CapEx

CapEx at other companies

Eli LillyLLY

$2.33B+54.0%

AmgenAMGN

$712M+73.2%

Ionis PharmaceuticalsIONS

$21.76M+73.0%

Arrowhead ResearchARWR

$2.57M-51.6%

CRISPR TherapeuticsCRSP

$504K+145%

ModernaMRNA

$62M-47.0%

Other financials

Income statement

See full

Revenue$136.0M-2.2%

Operating income-$169.0M-18.2%

Net income-$185.0M-22.5%

EPS (diluted)-$1.84-17.2%

Balance sheet

See full

Cash & equivalents$175.0M+37.8%

Total debt$36.0M-10.8%

Total equity-$236.0M-264%

Total assets$1.3B-1.2%

Cash flow

See full

Operating cash flow-$197.0M-18.7%

Free cash flow-$198.0M-18.6%

Valuation

See full

Market cap$2.83B-39.4%

P/S4.2×-3.7×

Profitability

See full

Gross margin97.2%—

Operating margin-83.8%-3.0pp

Net margin-90.9%-2.1pp

FCF margin-75.1%+10.7pp

Returns & leverage

See full

Return on equity-325.6%+36.9pp

Debt / equity3.7×—

Current ratio2×-0.4×

Where this comes from

Reported directly by Ultragenyx Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ultragenyx Pharmaceutical's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ultragenyx Pharmaceutical's capex?: Ultragenyx Pharmaceutical (RARE) reported capex of $1M in Q1 2026.
How has Ultragenyx Pharmaceutical's capex changed year-over-year?: Ultragenyx Pharmaceutical's capex decreased by 0.0% year-over-year, from $1M to $1M.
What is the long-term trend for Ultragenyx Pharmaceutical's capex?: Over 4 years (2021 to 2025), Ultragenyx Pharmaceutical's capex has grown at a -46.5% compound annual growth rate (CAGR), from $73.09M to $6M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.